Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Damora Therapeutics, a biotechnology company focused on treatments for blood disorders, announced its redomestication from Delaware to the Cayman Islands effective July 16, 2026. The company's shares will continue to trade on Nasdaq under the symbol DMRA with a new CUSIP. The redomestication does not change the company's operations or management.
Amneal Pharmaceuticals has obtained FDA approval for new strengths and vial sizes of its iohexol injection, a radiographic contrast agent used in various imaging procedures. The expanded portfolio is set to meet most of the U.S. iohexol injection market demand, positioning Amneal as a key player in complex injectables and hospital products. The com…
VisionWave Holdings announces filing of a provisional patent application for GhostSight™, a hybrid passive radar system that combines environmental RF signals with distributed cooperative illuminators, enhanced by AI/ML fusion for improved detection, classification, and situational awareness across defense and security sectors.
Ecolab is a durable, cash-generative leader in water, hygiene and thermal-management services. Recent results show low-single-digit organic growth, solid margin expansion and healthy free cash flow. The $4.75B CoolIT acquisition gives Ecolab direct exposure to the fast-growing AI data-center cooling market, adding near-term revenue and long-term op…
Grindr is showing durable paid-user strength and profitable growth that the market is under-appreciating. With revenue up ~28% y/y to $440M in 2025 and net income returning to $95M, the stock at $15.76 is offering asymmetric upside toward $20 while still managing meaningful downside risk from leverage and governance noise. We upgrade the rating and…
FedEx's freight unit sits with spare capacity while overall freight demand shows signs of recovery. At $318, the stock trades at ~17x earnings with solid free cash flow and room for margin recovery if pricing normalizes. This trade targets a re-test of the $345 area over the next 45 trading days with a disciplined stop below $298.
Edible Garden AG Incorporated announced that Wakefern Food Corp. is expanding the Garden Starters pallet display program with a midsummer promotional event at participating ShopRite locations. The program features USDA Organic Certified living herb plants to meet rising consumer demand for fresh, sustainable produce and promote home gardening. Edib…
Clearmind Medicine Inc., trading as CMND on Nasdaq, applauds recent developments by multiple U.S. federal agencies including FDA, HHS, VA and others, which support the advancement of psychedelic-based therapies for neuropsychiatric and addiction disorders. The company highlights regulatory progress such as final FDA guidance on psychedelic clinical…
Streamex Corp. (NASDAQ: STEX) announced the fourth monthly yield distribution for GLDY, its yield-bearing gold token, covering June 2026. The yield, generated through an institutional gold leasing program, is currently at an annualized rate of 3.9%, providing GLDY holders with monthly additional tokens as dividends. This yield outperforms tradition…
Camping World Holdings, Inc., the largest US retailer of RVs and related products, announced the release date for its second quarter 2026 financial results. The earnings will be released after market close on July 29, 2026, followed by a conference call on July 30 to discuss the results with investors and analysts.
Artiva Biotherapeutics announced the approval of inducement grants of 288,800 restricted stock units for 17 new employees under its 2025 Inducement Plan. These grants are intended to attract talent to support the company’s development of cell therapies targeting autoimmune diseases, including ongoing clinical trials for AlloNK therapy.
Evaxion A/S will present three-year clinical efficacy data from its phase 2 trial of personalized cancer vaccine EVX-01 at the upcoming ESMO Congress 2026. The data includes insights on EVX-01's durability and effectiveness as a stand-alone treatment for advanced melanoma. Previous two-year results showed high response rates and sustained immune re…
Headlines and volatile sector sentiment have amplified the bear case on Webull. We believe the market is over-discounting monetization upside and franchise value. This trade lays out a disciplined long with entry, stop, and target, and a clear catalyst checklist to re-rate the stock.
AmpliTech Group, Inc., a US-based developer of advanced RF and 5G systems, announced its membership in the AI-RAN Alliance, a global consortium focused on embedding AI into radio access network technology. This move aligns AmpliTech with industry leaders to drive innovation in AI-powered wireless infrastructure amid a rapidly growing AI-RAN market …
Balchem Corporation announced its second quarter 2026 financial results will be released before market open on July 31, 2026, followed by a conference call hosted by CEO Ted Harris and CFO Martin Bengtsson. The company provides specialty ingredients for human and animal nutrition as well as specialty products across various industries.
Kalaris Therapeutics reported positive results from its Phase 1a single ascending dose trial of TH103 for neovascular age-related macular degeneration (AMD). The expanded cohort data showed robust improvements in vision and retinal anatomy, with prolonged biological activity and reduced need for re-treatment. No significant adverse inflammation was…
MoonFox Data, a sub-brand of Aurora Mobile (NASDAQ: JG), has significantly expanded its offline consumer foot traffic dataset to cover over 300 additional stocks spanning China's A-shares, Hong Kong blue chips, and selected US-listed global consumer brands. This expansion includes broader sector coverage beyond consumer-facing companies to energy, …
Click Holdings Limited (NASDAQ: CLIK), a Hong Kong-based leader in AI-powered human resources and senior care solutions, has delivered over 6 million senior care hours, marking a milestone in its growth and social impact. The company reports strong financial results with a 73% year-over-year revenue increase and a strategic expansion plan targeting…
Tilray Brands, through its ownership of BrewDog, is launching a £1 million bar tab across its BrewDog pubs in Scotland, England, and Ireland. The initiative aims to unite football fans by offering two free pints per person via the BrewDog Treats loyalty platform between July 20 and September 30, 2026. This campaign will coincide with major sports e…
Ridgepost Capital, a leading private markets solutions provider listed on the NYSE as RPC, announced it will release its second quarter 2026 financial results before the market opens on August 5, 2026, followed by an investor conference call. The company manages over $45 billion in assets across private equity, private credit, and venture capital f…
POSCO Holdings (PKX) looks like a tactical long after recent investor-event takeaways that reinforced the company’s pivot into EV battery materials and steady steel sales. Fundamentals and technicals support a mid-term rebound toward the $60s while valuation is reasonable given a low PB and a 2.7% yield. Trade plan: enter at $51.22, stop at $47.00,…
CrossAmerica Partners LP, a leading wholesale distributor of motor fuels and convenience store operator in the U.S., announced it will release its second quarter 2026 earnings results on August 5, 2026, followed by a conference call on August 6. The company operates a nationwide footprint across 34 states, distributing petroleum products to about 1…
Costamare Bulkers Holdings Limited announced that its Board of Directors has scheduled the 2026 annual meeting of shareholders to be held virtually on October 8, 2026. Shareholders of record as of August 13, 2026, will receive notices and proxy statements shortly after.
Inhibrx is transitioning from clinical-stage story to commercial-stage execution with a recently launched rare-disease asset and a high-value oncology program approaching a Phase 2 readout. The market currently prices the company like a binary, high-volatility biotech. I favor a structured long: buy on weakness, trim into rallies, and hold through …
Annaly (NLY) just looks cheaper and more resilient than I allowed for earlier. A visible shift in portfolio mix toward higher-yielding residential credit and mortgage servicing rights, plus a raised quarterly dividend of $0.75, means Q2 should validate improving earnings power. At $23.50 entry, this is a pragmatic swing trade: buy on the mix story …
